Etlik City Hospital
Ankara, 06170, Turkey (Türkiye)
Location status: Recruiting
NCT Number: NCT06538779
The aim of the study is to evaluate the prevalence of bifid median nerve in patients diagnosed with carpal tunnel syndrome (CTS) and whether it has a higher prevalence in CTS patients than in asymptomatic individuals, and to evaluate the characteristics of the bifid median nerve found and whether median nerve variations are predisposing factors in the development of CTS.
Interested in participating?
Request Info18 year–65 year
All sexes
Observational
Ankara, 06170, Turkey (Türkiye)
Location status: Recruiting
Patients diagnosed with carpal tunnel syndrome electrophysiologically who applied to Etlik City Hospital physical therapy outpatient clinic will be included in the study.There are no sensitive groups.The research period was determined as 1 year.The sample size was done using G Power 3.1.9.4 statistical power analysis program for Windows.Based on the study conducted by Walker FO et al., the number of patients that would provide a significant difference (with a margin of error of 5% Type 1 and 20% Type 2, a study power of 80% and a confidence interval of 95%) was found to be 129 patients in total.Demographic and clinical characteristics of patients who meet the inclusion criteria and fill out the "Informed Consent Forum" will be recorded.General pain of the patients will be evaluated with the Visual Analogue Scale (Global Pain), symptom severity and functional status will be evaluated with the Boston Carpal Tunnel Questionnaire, and hand grip strength measurement will be evaluated with a dynamometer.The patient hand diagram will be marked according to the patient's sensory symptoms.Median nerve cross-sectional area will be measured at the pisiform level with ultrasound, and distal motor latency and sensory nerve conduction velocity will be measured with EMG and recorded.Median nerve stiffness will be evaluated by real-time elastography.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients' general pain will be assessed with Visual Analog Scale (Global Pain), symptom severity and functional status will be assessed with Boston Carpal Tunnel Questionnaire, hand grip strength will be measured with dynamometer. Patient hand diagram will be marked according to patient's sensory symptoms. Median nerve cross-sectional area measurement at pisiform level with ultrasound, distal motor latency and sensory nerve conduction velocity with emg will be performed and recorded. Median nerve stiffness will be assessed with real-time elastography.
Time frame: This evaluation will be made and recorded at the beginning
The VAS used for pain assessment consists of a line drawn in the form of a ruler,and numbers from 0 to 10(with 0 as ''no pain'' and 10 as ''unbearable pain'') were asked to score.
Time frame: This evaluation will be made and recorded at the beginning.
symptom severity and functional status scale
Time frame: This evaluation will be made and recorded at the beginning.
Hand grip strength measurement test
Time frame: This evaluation will be made and recorded at the beginning.
Median nerve cross-sectional area measurement at the pisiform level.
Time frame: This evaluation will be made and recorded at the beginning.
Median nerve stiffness will be evaluated by real-time strain/sheer elastography.
Contact information is provided by the study sponsor or research team.
Ayşegül YAMAN, specialist
CONTACT
Yunus Burak BAYIR, specialist
CONTACT
Yunus Burak Bayır
Other Gov
Sonographic Examination of Median Nerve Variations and Characteristics Observed in Healthy and Carpal Tunnel Syndrome Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07660913
Carpal Tunnel Syndrome, Cumulative Trauma Disorders
Izmir, Turkey (Türkiye)
View Trial DetailsNCT07614425
Carpal Tunnel Syndrome, Cumulative Trauma Disorders
Helsinki, Finland
View Trial DetailsNCT06239259
Carpal Tunnel Syndrome, Cumulative Trauma Disorders
Bangkok Noi, Bangkok, Thailand
View Trial DetailsNCT07324005
Carpal Tunnel Release, Carpal Tunnel Syndrome
Taipei, Taiwan
View Trial Details